IMAC Holdings Inc. Unveils Ignite Proteomics Subsidiary and Introduces Innovative Precision Oncology Case Study Featuring RPPA Technology
CS Genetics and ROSALIND® Join Forces to Expand Access to Single-Cell Genomics
Neuberg Diagnostics Unveils Geniee: A Personalized Genomics Platform
GE HealthCare's MIM Software Receives FDA Clearance for New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging
FDA Approves Merck's KEYTRUDA® (Pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy as a First-Line Treatment for Adults with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
OncoLens Introduces Real-Time Oncology Patient Identification for Clinical Trials and Essential Services
Biognosys and Thermo Fisher Sign Reselling Agreement for Spectronaut Proteomics Software
TVM Capital Healthcare Invests in Human Longevity Inc. to Drive Global Expansion of Precision Medicine
Circular Genomics Unveils MindLight™: The First SSRI Antidepressant Response Test Based on Brain-Derived Biomarkers
Pfizer Promotes BRAF Mutation Testing in Lung Cancer to Expand Braftovi Market
Immuneel Therapeutics Appoints Amit Mookim as New CEO
Celyad Oncology Appoints Matt Kane as Chief Executive Officer
Amrita Hospital in Faridabad Establishes Center of Excellence for CAR T-Cell Therapy
Exact Sciences' Blood-Based Colon Cancer Screening Data Surpasses Expectations at ESMO
Velsera Technology Achieves Milestone with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD, Advancing Cancer Diagnostics